Literature DB >> 2136898

Natural killer cells in the thymus. Studies in mice with severe combined immune deficiency.

B A Garni-Wagner1, P L Witte, M M Tutt, W A Kuziel, P W Tucker, M Bennett, V Kumar.   

Abstract

The relationship between NK cell and T cell progenitors was investigated by using mice with severe combined immune deficiency (scid). Scid mice are devoid of mature T and B cells because they cannot rearrange their Ig and TCR genes. However, they have normal splenic NK cells. Thymus of scid mice, although markedly hypocellular, contains cells that lyse YAC-1, an NK-sensitive tumor cell. By flow cytometry, two populations of cells were identified in the scid thymus. Eighty percent of the cells were Thy-1+, IL-2R(7D4)+, J11d+, CD3-, CD4-, CD8- whereas the remaining were IL-2R-, J11d-, CD3-, CD4-, and CD8-. By cell sorting, all NK activity was found in the latter population, which is phenotypically similar to splenic NK cells. To determine if the thymus contains a bipotential NK/T progenitor cell, J11d+, IL-2R+ cells were cultured and analyzed for the generation of NK cells in vitro. These cells were used because they resemble 15-day fetal and adult CD4- CD8- thymocytes that are capable of giving rise to mature T cells. Cultured J11d+ thymocytes acquired non-MHC-restricted cytotoxicity, but in contrast to mature NK cells, the resulting cells contained mRNA for the gamma, delta, and epsilon-chains of CD3. This suggests that J11d+ cells are early T cells that can acquire the ability to kill in a non-MHC-restricted manner, but which do not give rise to NK cells in vitro. The differentiative potential of scid thymocytes was also tested in vivo. Unlike bone marrow cells, scid thymocytes containing 80% J11d+ cells failed to give rise to NK cells when transferred into irradiated recipients. Together these results suggest that mature NK cells reside in the thymus of scid mice but are not derived from a common NK/T progenitor.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2136898

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  15 in total

Review 1.  Current status review: the severe combined immunodeficient (SCID) mouse: xenogeneic-SCID chimeras in the investigation of human autoimmune disease.

Authors:  P C Taylor
Journal:  Int J Exp Pathol       Date:  1992-04       Impact factor: 1.925

Review 2.  Investigation of NK cell function and their modulation in different malignancies.

Authors:  Gordana Konjevic; Vladimir Jurisic; Viktor Jovic; Ana Vuletic; Katarina Mirjacic Martinovic; Sandra Radenkovic; Ivan Spuzic
Journal:  Immunol Res       Date:  2012-04       Impact factor: 2.829

3.  Biased T-cell receptor delta element recombination in scid thymocytes.

Authors:  A M Carroll; J K Slack; W T Chang
Journal:  Mol Cell Biol       Date:  1993-06       Impact factor: 4.272

4.  Abnormal patterns of equine leucocyte differentiation antigen expression in severe combined immunodeficiency foals suggests the phenotype of normal equine natural killer cells.

Authors:  D P Lunn; J T McClure; C S Schobert; M A Holmes
Journal:  Immunology       Date:  1995-03       Impact factor: 7.397

5.  Both immunity and hyperresponsiveness to Pneumocystis carinii result from transfer of CD4+ but not CD8+ T cells into severe combined immunodeficiency mice.

Authors:  J B Roths; C L Sidman
Journal:  J Clin Invest       Date:  1992-08       Impact factor: 14.808

Review 6.  In vivo models of human lymphopoiesis and autoimmunity in severe combined immune deficient mice.

Authors:  T S Barry; B F Haynes
Journal:  J Clin Immunol       Date:  1992-09       Impact factor: 8.317

7.  Localization and identification of granzymes A and B-expressing cells in normal human lymphoid tissue and peripheral blood.

Authors:  J A Kummer; A M Kamp; T M Tadema; W Vos; C J Meijer; C E Hack
Journal:  Clin Exp Immunol       Date:  1995-04       Impact factor: 4.330

Review 8.  Potential of the scid mouse as a host for human tumors.

Authors:  B M Mueller; R A Reisfeld
Journal:  Cancer Metastasis Rev       Date:  1991-10       Impact factor: 9.264

9.  Therapeutic effect of granulocyte colony-stimulating factor (G-CSF) on the protection against Listeria infection in SCID mice.

Authors:  S Kayashima; S Tsuru; N Hata; M Rokutanda
Journal:  Immunology       Date:  1993-11       Impact factor: 7.397

10.  Rapid tumor formation of human T-cell leukemia virus type 1-infected cell lines in novel NOD-SCID/gammac(null) mice: suppression by an inhibitor against NF-kappaB.

Authors:  M Zahidunnabi Dewan; Kazuo Terashima; Midori Taruishi; Hideki Hasegawa; Mamoru Ito; Yuetsu Tanaka; Naoki Mori; Tetsutaro Sata; Yoshio Koyanagi; Michiyuki Maeda; Yoko Kubuki; Akihiko Okayama; Masahiro Fujii; Naoki Yamamoto
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.